JP2021529243A5 - - Google Patents

Info

Publication number
JP2021529243A5
JP2021529243A5 JP2020573107A JP2020573107A JP2021529243A5 JP 2021529243 A5 JP2021529243 A5 JP 2021529243A5 JP 2020573107 A JP2020573107 A JP 2020573107A JP 2020573107 A JP2020573107 A JP 2020573107A JP 2021529243 A5 JP2021529243 A5 JP 2021529243A5
Authority
JP
Japan
Prior art keywords
substance
cyclodextrin
hydroxypropyl
less
ppm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020573107A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021529243A (ja
JP7581055B2 (ja
Filing date
Publication date
Priority claimed from FR1855952A external-priority patent/FR3083234B1/fr
Application filed filed Critical
Priority claimed from PCT/FR2019/051602 external-priority patent/WO2020002851A1/fr
Publication of JP2021529243A publication Critical patent/JP2021529243A/ja
Publication of JP2021529243A5 publication Critical patent/JP2021529243A5/ja
Priority to JP2024130931A priority Critical patent/JP2024150779A/ja
Application granted granted Critical
Publication of JP7581055B2 publication Critical patent/JP7581055B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020573107A 2018-06-29 2019-06-28 新規なヒドロキシプロピル-β-シクロデキストリン及びそれを生成するための方法 Active JP7581055B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024130931A JP2024150779A (ja) 2018-06-29 2024-08-07 新規なヒドロキシプロピル-β-シクロデキストリン及びそれを生成するための方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR1855952 2018-06-29
FR1855952A FR3083234B1 (fr) 2018-06-29 2018-06-29 Nouvelles hydroxypropyl-beta-cyclodextrines et leurs procedes de preparation
FR1902375 2019-03-08
FR1902375 2019-03-08
PCT/FR2019/051602 WO2020002851A1 (fr) 2018-06-29 2019-06-28 NOUVELLE HYDROXYPROPYL-β-CYCLODEXTRINE ET SON PROCÉDÉ DE PRÉPARATION

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024130931A Division JP2024150779A (ja) 2018-06-29 2024-08-07 新規なヒドロキシプロピル-β-シクロデキストリン及びそれを生成するための方法

Publications (3)

Publication Number Publication Date
JP2021529243A JP2021529243A (ja) 2021-10-28
JP2021529243A5 true JP2021529243A5 (enExample) 2023-08-10
JP7581055B2 JP7581055B2 (ja) 2024-11-12

Family

ID=67551566

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020573107A Active JP7581055B2 (ja) 2018-06-29 2019-06-28 新規なヒドロキシプロピル-β-シクロデキストリン及びそれを生成するための方法
JP2024130931A Pending JP2024150779A (ja) 2018-06-29 2024-08-07 新規なヒドロキシプロピル-β-シクロデキストリン及びそれを生成するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024130931A Pending JP2024150779A (ja) 2018-06-29 2024-08-07 新規なヒドロキシプロピル-β-シクロデキストリン及びそれを生成するための方法

Country Status (10)

Country Link
US (1) US12522670B2 (enExample)
EP (1) EP3814386A1 (enExample)
JP (2) JP7581055B2 (enExample)
KR (1) KR102912248B1 (enExample)
CN (1) CN112334494A (enExample)
CA (1) CA3104568A1 (enExample)
IL (1) IL279845A (enExample)
MX (1) MX2020013689A (enExample)
SG (1) SG11202013126QA (enExample)
WO (1) WO2020002851A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11279774B2 (en) 2019-01-03 2022-03-22 Underdog Pharmaceuticals, Inc. Cyclodextrin dimers, compositions thereof, and uses thereof
KR20240160120A (ko) 2022-02-18 2024-11-08 베렌 테라퓨틱스 피.비.씨. 하이드록시프로필-베타-사이클로덱스트린의 조성물 및 이의 정제 방법
JP2024064599A (ja) * 2022-10-28 2024-05-14 国立大学法人 熊本大学 細胞内コレステロール輸送障害に起因する疾患又は障害の治療、予防又は改善用組成物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346123A1 (de) 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
AU631628B2 (en) * 1989-04-03 1992-12-03 Janssen Pharmaceutica N.V. Regioselectively hydroxyalkylated cyclodextrins and process therefor
US5096893A (en) 1989-04-03 1992-03-17 The United States Of America As Represented By The Department Of Health And Human Services Regioselective substitutions in cyclodextrins
KR920008700A (ko) * 1990-10-29 1992-05-28 이헌조 데크의 테이프 삽입유무 표시방법
DE19505263A1 (de) * 1995-02-16 1996-08-22 Consortium Elektrochem Ind Verfahren zur Reinigung von wasserlöslichen Cyclodextrinderivaten
FR2735136B1 (fr) 1995-06-08 1997-08-14 Roquette Freres Composition pulverulente d'hydroxypropyl-betacyclodextrine et son procede de preparation.
CN1155888A (zh) 1995-06-08 1997-07-30 火箭兄弟公司 粉状羟丙基-β-环糊精组合物和其制备方法
FR2738149B1 (fr) * 1995-09-06 1997-11-14 Chauvin Lab Sa Collyre a base d'indometacine pret a l'emploi
US5744154A (en) 1995-09-06 1998-04-28 Laboratoire Chauvin S.A. Ready-to-use indomethacin-based eye lotion
EP1655034A1 (en) 2004-10-10 2006-05-10 Université de Liège Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases.
PH12013500477A1 (en) 2010-09-13 2018-01-17 Bev Rx Inc Aqueous drug delivery system comprising off-flavor masking agent
CN102558394B (zh) * 2010-12-07 2014-11-12 石药集团中奇制药技术(石家庄)有限公司 羟丙基-β-环糊精的制备方法
CN102040675B (zh) * 2010-12-22 2012-10-03 石药集团中诺药业(石家庄)有限公司 一种羟丙基-β-环糊精的制备方法
EP2726106B1 (en) 2011-07-01 2015-07-29 Fondazione Istituto Insubrico di Ricerca per la Vita A complex of amorphous tomoxiprole and cyclodextrin with fast dissolution rate and process for the preparation thereof
FR3014694B1 (fr) * 2013-12-13 2016-11-11 Roquette Freres Compositions a base de methyl-cyclodextrines pour le traitement et/ou la prevention de maladies par augmentation du taux de cholesterol-hdl
EP3307278A4 (en) * 2015-06-10 2018-06-13 Vtesse, Inc. Hydroxypropyl beta-cyclodextrin compositions and methods
CN108034010A (zh) 2017-12-29 2018-05-15 山东滨州智源生物科技有限公司 一种羟丙基环糊精的绿色制备方法

Similar Documents

Publication Publication Date Title
JP2994037B2 (ja) 医 薬
UA79196C2 (en) Intranasal formulation of rotigotine
JP5566408B2 (ja) ドライシロップ剤
JPS5837284B2 (ja) セイヤクソセイブツノセイホウ
JP2019509268A5 (enExample)
CN102427811A (zh) 适于局部治疗皮肤和指(趾)甲真菌感染的组合物
JP4959019B2 (ja) ヘスペリジン含有組成物
WO2012117257A1 (en) Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer
JP2009520802A (ja) 親水コロイドを用いた、精油の味覚マスキング
JP6505114B2 (ja) 抗酸化剤を含有しない薬学組成物およびその製造方法
CN103491933B (zh) 口腔护理组合物
HUP0100211A2 (hu) Új polietoxilezett ricinusolaj, eljárás annak előállítására és azt tartalmazó készítmények
JP7857271B2 (ja) 医薬活性化合物の苦味抑制剤及び苦味抑制方法
CN103402490B (zh) 洁齿剂组合物
JP6050031B2 (ja) フィルム製剤
KR102912248B1 (ko) 신규 히드록시프로필-β-사이클로덱스트린 및 이의 제조 방법
KR101140203B1 (ko) 펠라르고늄 시도이데스 및 펠라르고늄 레니포르메로부터의 건조 추출물
EP3503885B1 (en) Pharmaceutical composition and methods of uses
RU2216549C2 (ru) Пиперазин-циклодекстриновый комплекс и лекарственное средство, содержащее указанный комплекс
JP4890657B1 (ja) リマプロストとβ−シクロデキストリンを含有する錠剤
JP6549428B2 (ja) 経口組成物
JPH082773B2 (ja) ロ−シヨン組成物
JP4826051B2 (ja) スチルベン誘導体の新規結晶及びその製造方法
JP2014518228A5 (enExample)
MXPA04011777A (es) Composicion farmaceutica.